background
data
relationship
clinic
microbiolog
featur
communityacquir
pneumonia
cap
comput
tomographi
ct
find
limit
aim
present
studi
investig
clinicmicrobiolog
featur
patient
cap
present
groundglass
opac
ggo
centrilobular
nodul
treeinbud
pattern
ct
imag
method
patient
cap
underw
ct
scan
present
retrospect
classifi
use
ct
find
consolid
ggo
bronchiol
group
group
compar
term
clinic
paramet
microbiolog
data
result
total
patient
alloc
bronchiol
group
ggo
group
common
pathogen
bronchiol
group
mycoplasma
pneumonia
significantli
frequent
isol
group
bronchiol
group
character
higher
percentag
cough
lower
percentag
chest
pain
lower
blood
level
inflammatori
marker
common
pathogen
ggo
group
significantli
differ
group
unlik
observ
consolid
group
complic
parapneumon
effus
empyema
observ
bronchiol
ggo
group
outcom
variabl
similar
group
conclus
bronchiol
group
character
higher
frequenc
pneumonia
less
sever
form
cap
ggo
consolid
group
similar
respect
caus
microorgan
clinic
featur
cap
patient
bronchiol
ggo
group
exhibit
complic
parapneumon
effus
empyema
c
ommunityacquir
pneumonia
cap
remain
import
caus
morbid
mortal
worldwid
despit
use
antibiot
armamentarium
avail
vaccin
therefor
earli
diagnosi
appropri
antimicrobi
treatment
critic
step
manag
cap
chest
radiographi
usual
use
combin
constel
compat
symptom
sign
cough
sputum
product
confirm
diagnosi
pneumonia
comput
tomographi
ct
use
plain
chest
radiograph
reveal
find
explain
patient
clinic
present
ct
imag
provid
detail
inform
regard
lung
parenchyma
suggest
specif
caus
agent
rule
noninfecti
pneumonia
detect
underli
condit
thu
ct
provid
addit
benefit
diagnosi
cap
aid
type
particular
perform
earli
ct
affect
diagnosi
clinic
manag
cap
emerg
depart
accordingli
use
ct
patient
suspect
cap
expect
increas
real
world
practic
varieti
microbi
agent
includ
typic
atyp
pathogen
caus
cap
consider
number
studi
ct
find
cap
trigger
differ
pathogen
includ
streptococcu
pneumonia
klebsiella
pneumonia
mycoplasma
pneumonia
chlamydia
pneumonia
legionella
pneumophila
publish
patient
cap
attribut
specif
pathogen
present
ct
pattern
although
pattern
predomin
cap
classic
divid
pattern
base
ct
find
consolidationpredomin
peribronchi
nodulespredomin
groundglass
opac
ggo
predomin
howev
data
relationship
clinic
microbiolog
featur
cap
ct
find
scarc
cap
pure
nearli
pure
ggo
lesion
uncommon
regardless
caus
pathogen
ct
find
multipl
centrilobular
nodul
also
rare
hypothes
clinic
manifest
patient
cap
relat
ct
find
thu
compar
clinic
featur
microbiolog
data
cap
patient
classifi
base
ct
find
retrospect
enrol
consecut
patient
cap
admit
treat
respiratori
depart
kyungpook
nation
univers
hospit
knuh
tertiari
referr
center
daegu
south
korea
januari
decemb
baselin
patient
characterist
record
admiss
although
patient
underw
laboratori
test
pneumonia
diagnos
use
follow
criteria
new
radiograph
infiltr
symptom
sign
consist
pneumonia
cough
sputum
dyspnea
fever
pleurit
chest
pain
exclus
caus
patient
hospitalacquir
pneumonia
healthcareassoci
pneumonia
activ
thorac
malign
take
immunosuppress
steroid
mgday
prednison
day
exclud
patient
without
avail
chest
ct
scan
present
also
exclud
ct
find
cap
classifi
categori
bronchiol
ggo
consolid
group
compar
term
clinic
characterist
microbiolog
data
studi
approv
institut
review
board
knuh
waiv
requir
written
inform
patient
consent
retrospect
natur
studi
two
chest
radiologist
jkl
km
review
chest
ct
scan
patient
cap
classifi
group
figur
bronchiol
group
chest
ct
indic
centrilobular
nodul
treeinbud
pattern
lesion
minim
ggo
consolid
figur
ggo
group
chest
ct
indic
focal
diffus
ggo
minim
centrilobular
nodul
treeinbud
pattern
consolid
consolid
group
chest
ct
indic
consolid
without
variabl
extent
ct
featur
bronchiol
ggo
two
chest
physician
hs
sic
review
medic
record
resid
physician
initi
record
baselin
data
confirm
attend
chest
physician
demograph
data
includ
age
sex
smoke
histori
alcohol
consumpt
heavi
drink
defin
consumpt
drink
g
alcohol
occas
men
drink
g
alcohol
occas
women
least
twice
week
review
symptom
vital
sign
comorbid
pneumonia
sever
indic
score
eastern
cooper
oncolog
group
ecog
perform
status
retrospect
calcul
charlson
comorbid
indic
use
mechan
ventil
corticosteroid
treatment
vasopressor
infus
pleural
drainag
percutan
cathet
chest
tube
check
outcom
variabl
includ
length
hospit
stay
mortal
inhospit
mortal
clinic
success
treatment
success
defin
improv
clinic
symptom
sign
radiolog
find
laboratori
data
includ
complet
blood
count
erythrocyt
sediment
rate
liver
function
test
creactiv
protein
crp
procalcitonin
ntermin
prohormon
brain
natriuret
peptid
blood
urea
nitrogen
creatinin
sodium
lactat
dehydrogenas
lactat
arteri
blood
ga
analysi
criteria
caus
pathogen
follow
microorgan
isol
blood
pleural
fluid
posit
urinari
antigen
test
pneumonia
l
pneumophila
serogroup
binaxnow
pneumonia
legionella
urinari
antigen
card
aler
scarborough
cultur
bacteria
sputum
sampl
neutrophil
squamou
epitheli
cell
per
lowpow
field
collect
within
hour
admiss
plu
compat
gramstain
find
identif
pneumonia
base
posit
immunoglobulin
igm
result
increas
immunoglobulin
g
igg
level
convalesc
versu
initi
blood
sampl
chemiluminesc
immunoassay
liaison
diasorin
saluggia
itali
posit
pneumonia
sputum
polymeras
chain
reaction
pcr
amplisen
mycoplasma
pneumoniaefep
pcr
central
research
institut
epidemiolog
moscow
russia
presenc
c
pneumonia
determin
posit
igm
increas
igg
level
microimmunofluoresc
inhous
method
enzymelink
immunosorb
assay
diess
diagnostica
senes
monteriggioni
itali
posit
respiratori
viru
enteroviru
throat
nasopharyng
swab
determin
multiplex
pcr
anyplex
detect
seegen
seoul
korea
identif
influenza
b
antigen
throat
swab
rapid
chromatograph
immunoassay
sd
biolin
influenza
antigen
test
standard
diagnost
yongin
korea
bd
veritor
system
rapid
detect
bd
diagnost
spark
md
data
express
median
interquartil
rang
continu
variabl
number
percentag
categor
variabl
continu
variabl
compar
use
kruskalw
test
dunn
test
use
posthoc
test
categor
variabl
compar
use
chisquar
test
among
group
bonferroni
correct
use
posthoc
followup
test
kappa
statist
use
measur
interinterpret
agreement
regard
ct
find
ibm
spss
statist
window
version
ibm
corp
armonk
ny
use
statist
analysi
p
consid
statist
signific
initi
patient
cap
identifi
patient
without
avail
ct
scan
patient
identifi
parenchym
lesion
due
parapneumon
effus
exclud
consequ
patient
includ
studi
patient
admit
n
radiologist
km
jkl
independ
review
ct
find
classifi
consolid
bronchiol
ggo
consensu
kappa
statist
remain
patient
radiologist
determin
ct
find
patient
includ
bronchiol
group
ggo
group
consolid
group
clinic
microbiolog
variabl
group
compar
clinic
paramet
present
tabl
percentag
patient
cough
differ
significantli
among
group
percentag
significantli
greater
bronchiol
group
consolid
group
versu
p
frequenc
chest
pain
significantli
blood
level
crp
procalcitonin
albumin
total
protein
sodium
significantli
differ
group
tabl
crp
mgdl
mgdl
versu
mgdl
mgdl
p
procalcitonin
ngml
ngml
versu
ng
ml
ngml
p
significantli
lower
bronchiol
group
consolid
group
bronchiol
group
significantli
higher
blood
level
albumin
gdl
gdl
versu
gdl
gdl
p
total
protein
gdl
gdl
versu
gdl
gdl
p
consolid
group
microbiolog
data
summar
tabl
eight
hundr
fiftynin
potenti
pathogen
identifi
patient
pathogen
patient
consolid
group
initi
use
antibiot
summar
compar
group
tabl
thirdgener
cephalosporinor
ampicillinsulbactambas
regimen
commonli
use
group
signific
differ
antibiot
regimen
group
except
fluoroquinolon
without
aminoglycosid
higher
frequenc
fluoroquinolon
without
aminoglycosid
bronchiol
group
statist
signific
posthoc
analysi
compar
consolid
group
bonferroni
correct
p
studi
confirm
predominantli
bronchiol
ggo
pattern
ct
imag
uncommon
patient
cap
bronchiol
group
common
pathogen
pneumonia
follow
pneumonia
c
pneumonia
pneumonia
significantli
common
consolid
group
compar
consolid
group
bronchiol
group
character
higher
percentag
cough
lower
rate
chest
pain
pleural
effus
absenc
complic
parapneumon
effus
empyema
pleural
drainag
furthermor
bronchiol
group
associ
lower
blood
level
inflammatori
marker
higher
albumin
total
protein
level
blood
common
caus
pathogen
ggo
group
pneumonia
c
pneumonia
pneumonia
k
pneumonia
significantli
differ
observ
group
observ
bronchiol
group
complic
parapneumon
effus
empyema
observ
patient
underw
pleural
drainag
ggo
group
outcom
variabl
mortal
significantli
differ
among
group
centrilobular
nodul
ct
correspond
patholog
cellular
infiltr
bronchiol
exud
granul
tissu
bronchiolar
lumen
wherea
consolid
reflect
neutrophil
exud
alveolar
lumen
previou
studi
show
microbiolog
featur
cap
patient
treeinbud
pattern
share
similar
pneumonia
gener
popul
anoth
studi
pneumonia
infect
frequent
associ
bronchiol
pattern
pneumonia
affin
airway
cilia
bronchiol
caus
peribronchi
perivascular
infiltr
mononuclear
cell
edemat
ulcer
lesion
bronchial
wall
present
studi
case
bronchiol
group
caus
pneumonia
concur
find
previou
studi
pneumonia
determin
common
pathogen
diffus
acut
infecti
bronchiol
adult
interestingli
common
cap
pathogen
c
pneumonia
pneumonia
k
pneumonia
also
caus
bronchiol
pattern
mechan
respons
centrilobular
nodul
treeinbud
pattern
patient
consolid
ggo
other
explain
upor
downregul
host
cellmedi
immun
respect
previou
studi
rate
diffus
bronchiol
report
among
communityacquir
lower
respiratori
tract
infect
differ
rate
valu
found
present
studi
bronchiol
pattern
explain
differ
definit
use
present
studi
bronchiol
defin
either
presenc
centrilobular
nodul
treeinbud
pattern
lesion
without
ggo
consolid
present
studi
wherea
previou
studi
diffus
acut
infecti
bronchiol
defin
multipl
centrilobular
nodul
lobe
howev
previou
studi
address
clinic
manifest
bronchiol
bronchiolitispredomin
cap
expect
base
publish
find
bronchiol
group
exhibit
clinic
less
sever
form
cap
character
lower
level
inflammatori
marker
absenc
complic
parapneumon
effus
empyema
data
present
n
other
includ
macrolid
alon
n
glycopeptid
plu
clindamycin
n
fluoroquinolon
plu
clindamycin
plu
aminoglycosid
n
antipseudomon
betalactam
plu
clindamycin
n
thirdgener
cephalosporin
plu
glycopeptid
n
carbapenem
plu
aminoglycosid
plu
macrolid
n
fluoroquinolon
plu
glycopeptid
n
macrolid
plu
glycopeptid
n
thirdgener
cephalosporin
plu
aminoglycosid
n
